Labaran Halittu Biyu
A ranar 20 ga watan Agustan shekarar 2022, a gasar kirkire-kirkire da kasuwanci ta kasar Sin karo na 11 (layin Guangdong), Wu Guangming, shugaban sashen nazarin halittu na MingCeler, ya tsallake zuwa zagaye na karshe na lardin Guangdong, tare da aikinsa na "Mai saurin tsara nau'in linzamin kwamfuta na zamani", mai taken "Mai saurin samar da nau'in linzamin kwamfuta na zamani". fasahar ci-gaba a duniya.
An bayyana cewa, wannan gasa bayan tantancewar farko, sama da kamfanoni 5000, da kamfanoni sama da 370 ne suka shiga zagayen karshe, inda aka fitar da jimillar kamfanoni 24 da ke rukunin farko na fannin kimiyyar rayuwa a zagayen karshe.MingCeler ta yi nasara a matsayi na uku a rukunin farko na gwaji kuma tana sa ran za ta yi fice a wasan karshe na lardin Guangdong.
Haske a wurin
Domin aiwatar da tsarin cikakken zaman taro karo na shida na kwamitin tsakiya na JKS karo na 19, da taron kolin tattalin arzikin tsakiya na jam'iyyar kwaminis ta kasar Sin, da kuma kara aiwatar da dabarun raya kirkire-kirkire, gasar ta mai da hankali kan "Sirgaban kirkire-kirkire, harkokin kasuwanci na gina mafarkai", da kuma wannan. shine karo na farko ga MingCeler Biology don shiga gasar kirkire-kirkire biyu.Wanda ya kafa kamfanin, Wu Guangming, yana aiki a manyan cibiyoyin bincike na duniya a Amurka da Jamus tun daga shekarar 1995, kuma sunansa har abada a cikin gidan tarihi na Deutsches da ke Jamus saboda irin gudunmawar da ya bayar a fannin nazarin halittun ci gaba. .A farkon shekarar 2020, lokacin da COVID-19 ya kasance mummunar barazana ga lafiyar jama'a da amincin, Wu Guangming ya yi amfani da fasaharsa ta musamman ta "Tetraploid diyya" don samarwa da kuma isar da ACE2, samfurin linzamin kwamfuta na sabon maganin kambi da haɓaka magunguna, zuwa bincike da yawa. cibiyoyi da yawa a cikin watanni 2.An ba shi lambar yabo mai suna "Mutum mai ci gaba a yaki da ciwon huhu na Neoplastic Pneumonia" a lardin Guangdong saboda rawar da ya taka wajen yaki da cutar huhu.
Aikin "Fasahar Shirye-Shirfi don Sabbin Samfuran Dabbobi" ya dogara ne akan tarin tarin shekaru na Wu Guangming, ingantaccen ingantaccen "fasaharar diyya ta tetraploid", tare da ikon mallaka mai zaman kanta da matakin aiki na duniya, da kafa aikin injiniya. tsarin.A cikin Janairu 2022, mai bincike Guangming Wu ya kafa Guangzhou MingCeler Biotechnology Co. Kamfanin yana mai da hankali kan sauya fasahar diyya ta tetraploid, haɓaka sabbin fasahohin ƙirar linzamin kwamfuta tare da rushewar masana'antu, karya shingen fasaha na yanzu a masana'antar shirya ƙirar linzamin kwamfuta, cimma nasara. makasudin gajarta zagayowar ƙirar ƙira, saurin gyare-gyaren da aka yi niyya, rage farashin samarwa, da haɓaka haɓakar samar da samfura masu wahala da rikitarwa.
Guangzhou MingCeler Biotech Co., Ltd (wanda ake magana da shi a matsayin MingCeler) ya ƙware a cikin sauri da kuma keɓance keɓance nau'ikan nau'ikan berayen da aka gyara ta asali, tare da babban matsayi a duniya a cikin zagayowar ƙirar ƙira, wanda zai iya zama gajere kamar watanni 2. samar da mice masu dacewa da tsaftataccen tsari da kuma ƙwararrun dabarun ba da shawara ga abokan ciniki.Mun himmatu wajen samar da sabbin ayyuka da albarkatu na fasahar kere-kere, ga sabbin kamfanoni na duniya, kamfanonin rigakafi, jami'o'i, cibiyoyin bincike, asibitoci, da sauran kungiyoyin bincike masu alaka da lafiya.
Babban fa'idodin fasaha
Babban inganci:Maganin fasahar diyya ta mu na musamman na tetraploid na iya haɓaka ƙimar haihuwar beraye daga mafi girman 1-5% da aka riga aka bayar da rahoton a duniya zuwa 30-60%, gaba ɗaya warware matsalar masana'antu na fasahar diyya ta tetraploid.
Mai sauri:Za a iya shirya cikakken mice guda ɗaya kai tsaye daga ƙwayoyin ƙwanƙwasawa na linzamin kwamfuta, ta ƙetare matakan kiwo na lokaci-lokaci na fasaha na al'ada, kuma ana iya taƙaita lokacin shirye-shiryen zuwa ƙasa da watanni 2 tare da babban nasara.
Zaɓuɓɓuka da yawa:nau'ikan nau'ikan da za a zaɓa daga, inbred, m, da matasan;yana ba da samfura masu yawa-wuri, dogon guntu hadaddun.
Lokacin aikawa: Agusta-02-2023